Evotec stock gains on Plectonic research deal

Published on 09/03/2026 at 06:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock rose after a September 2, 2026 research collaboration with Plectonic Biotech, while the latest cited market snapshot showed EUR 3.2240 on September 2, 2026.

Flatlay-Arrangement rund um Laborarbeitsplatz mit passenden Requisiten von oben — Flatlay-Arrangement rund um Laborarbeitsplatz zum Thema Evotec Forschung, ISIN DE0005664809, weiches Oberlicht, Illustration mit AI erstellt.

Evotec stock (ISIN DE0005664809) gained after the group announced on September 2, 2026 that it entered a research collaboration with Plectonic Biotech. The latest cited market snapshot showed the share at EUR 3.2240 on September 2, 2026, up 2.35 percent in the session.

Plectonic deal adds a dated catalyst

According to Evotec, the collaboration is aimed at a new generation of T-cell engaging approaches for solid tumors. The company also said on the same day that its expectations for revenues, Group EBITDA and unpartnered R&D expenses remain part of the forward-looking framework tied to the announcement.

Price and volume moved together

MarketBeat reported on September 2, 2026 that Evotec shares opened at USD 1.88 after a prior close of USD 1.80 and last traded at USD 1.9230, with volume of 11,906 shares. On the same day, Yahoo Finance showed EVT.DE at EUR 3.3060 at close on September 2, 2026, after a previous close of EUR 3.1500.

Go deeper

Evotec collaboration and share data

The latest company update and the most recent quoted price levels put the collaboration story and the stock move in one frame.

Evotec overview Investor Relations

Biotech platform stays central

Evotec described the Plectonic tie-up as a way to explore a novel immunotherapy approach for solid tumors, which keeps the company's partnered research model in view. For investors, the combination of collaboration news, a EUR 3.2240 snapshot, and a 2.35 percent rise on September 2, 2026 is the relevant short-term setup.

Stock level to watch

Evotec stock closed at EUR 3.3060 on September 2, 2026, according to Yahoo Finance, after trading at EUR 3.1500 the prior session. That leaves the share close to its latest quoted range, with the market reacting to the September 2 research announcement rather than to a new earnings release.